Heather Clipson

Heather Clipson serves as a key procurement professional within the Defense Health Agency, supporting the agency’s mission to deliver secure, high-quality healthcare services to uniformed service members, retirees, and their families. She manages a diverse portfolio of acquisitions focused on clinical infrastructure, medical technology, and operational support services, ensuring alignment with DoD standards for readiness and data integrity. Her work centers on acquiring critical healthcare-enabling solutions—from diagnostic and surgical equipment to secure data and facility services—while maintaining strict compliance with federal acquisition regulations and defense-specific requirements. Clipson maintains consistent partnerships with specialized vendors including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc., reflecting a preference for niche providers with expertise in medical device support, biosecurity, and precision instrumentation. Her contracting patterns emphasize long-term vendor relationships grounded in technical capability and regulatory compliance, particularly among firms experienced in military healthcare environments and defense-grade service delivery. A strong advocate for small business participation, Clipson routinely structures procurements with a 60% total small business set-aside under FAR 19.5, prioritizing socioeconomic programs that enhance diversity in the defense supply chain. Her approach ensures robust engagement with small businesses while maintaining performance standards critical to mission-critical healthcare operations. Her procurement focus is concentrated in NAICS 561621 (security systems services), 339112 (surgical and medical instrument manufacturing), 541380 (testing laboratories), and 811210 (electronic equipment repair and maintenance). This reflects deep expertise in procuring diagnostic tools, laboratory services, medical device lifecycle support, and secure facility operations—all essential to sustaining the DHA’s global clinical infrastructure and operational readiness posture.